Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2010
12/16/2010US20100317005 Modified Nucleotides and Methods for Making and Use Same
12/16/2010US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9
12/16/2010US20100316999 Nucleic Acid Sequence Analysis
12/16/2010US20100316994 Diagnosis and therapy of cancer using sgp28-related molecules
12/16/2010US20100316992 Diagnostic test
12/16/2010US20100316743 INHIBITION OF THE FORMATION OF AGEs
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316688 Methods for culturing stem and progenitor cells
12/16/2010US20100316653 Compositions and methods for diagnosis and treatment of orthopoxviruses
12/16/2010US20100316650 Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
12/16/2010US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof
12/16/2010US20100316642 Complexes of grp94 with human immunoglobulin g
12/16/2010US20100316635 Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same
12/16/2010US20100316634 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/16/2010US20100316626 Methods for treatment and diagnosis of psychiatric disorders
12/16/2010US20100316622 Diagnosis and treatment of cardiac disorders
12/16/2010US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316608 Method of Determining A Response To Treatment With Immunomodulatory Composition
12/16/2010US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy
12/16/2010US20100316572 Use of fsh receptor ligands for diagnosis and therapy of cancer
12/16/2010US20100316568 Diagnostic agent and therapeutic agent for pancreatic cancer
12/16/2010US20100316564 Immunological targeting of pathological tau proteins
12/16/2010US20100316563 Method For The Preparation Of New Oligoclonal Antibodies
12/16/2010US20100315624 Device for, an arrangement for and a method of analysing a sample
12/16/2010US20100314251 Diagnosis of Parkinson's disease
12/16/2010US20100313887 Method for operating a rebreather
12/16/2010US20100313649 Process for determining tissue product break-through
12/16/2010US20100313648 Process for demonstrating tissue product break-through
12/16/2010US20100313632 Method For Removing A Coating Comprising A Hazardous Compound From A Surface
12/16/2010US20100313631 Fluid Discrimination Method and Fluid Discrimination Apparatus
12/16/2010US20100313630 Machine tool and/or production machine
12/16/2010US20100313629 Preventing Soot Underestimation in Diesel Particulate Filters by Determining the Restriction Sensitivity of Soot
12/16/2010DE102009025326A1 Method for testing analytical substance in e.g. medical field for detecting e.g. existence of pregnancy, involves bringing rinsing fluid on analysis substrate, for transporting analytical substance to analysis substrate
12/16/2010DE10030854B4 Verfahren zur Ermittlung und/oder Erfassung des aktuellen Zustandes eines Schmiermittels Procedures for identifying and / or capture the current state of a lubricant
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010CA2767164A1 Methods for culturing stem and progenitor cells
12/16/2010CA2765314A1 Semiconductor biosensors
12/16/2010CA2765198A1 Device and method for determining the concentration of a compound in an aqueous or gaseous phase
12/16/2010CA2765167A1 A highly sensitive method for detection of viral hiv dna remaining after antiretroviral therapy of aids patients
12/16/2010CA2765163A1 Method and system to detect, diagnose, and monitor the progression of alzheimer's disease
12/16/2010CA2765099A1 Immunological targeting of pathological tau proteins
12/16/2010CA2764760A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy
12/16/2010CA2764646A1 Therapeutic agent and assay
12/16/2010CA2764637A1 Non-invasive monitoring of blood metabolite levels
12/16/2010CA2764617A1 Methods and kits for detecting, diagnosing and monitoring diseases
12/16/2010CA2764607A1 A diagnostic method
12/16/2010CA2764274A1 A method of diagnosing renal disorders
12/16/2010CA2764189A1 Use of lcat for treating anemia and red blood cell dysfunction
12/16/2010CA2763855A1 Methods of signal generation and signal localization for improvement of signal readability in solid phase based bioassays
12/16/2010CA2763852A1 Signal amplification microspheres, their use in one-step and multi-step analytical amplification procedures and methods for their production
12/16/2010CA2763842A1 An electrochemical method and apparatus of identifying the presence of a target
12/16/2010CA2763776A1 Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy
12/16/2010CA2762612A1 Highly sensitive biomarker panels
12/16/2010CA2751245A1 Molecular imprinted nanosensors
12/15/2010EP2261922A2 Playback apparatus and method, recording apparatus and method and recording medium
12/15/2010EP2261675A2 Analysis system
12/15/2010EP2261673A1 Method for preparing calibrating reagent, calibrating reagent, and method for calibrating blood component measuring device using said calibrating reagent
12/15/2010EP2261672A2 Biomarkers for early detection of ovarian cancer
12/15/2010EP2261671A2 Diagnostic assay for human Matrix-Gla-Protein and its use as a biomarker
12/15/2010EP2261670A2 Method and apparatus for assessing polypeptide aggregation
12/15/2010EP2261669A1 Diagnostic markers of acute coronary syndromes and methods of use thereof
12/15/2010EP2261668A1 Method for predicting glycaemic response and use thereof
12/15/2010EP2261667A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer
12/15/2010EP2261666A1 Method for detection of pneumococcus
12/15/2010EP2261665A2 Methods of diagnosing and treating Crohn's disease
12/15/2010EP2261664A2 Methods of treating bloating, abdominal pain and diarrhea
12/15/2010EP2261663A2 Method for quantifying a plurality of different analytes
12/15/2010EP2261662A1 Novel synthetic blocking reagents
12/15/2010EP2261661A1 Purified serum albumin, and immunological measurement method
12/15/2010EP2261660A1 Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker
12/15/2010EP2261659A2 Method of optical detection of binding of a material component to a sensor substance due to a biological, chemical or physical interaction and apparatus for its embodiment (variant)
12/15/2010EP2261658A2 IP-10 based infection diagnosis
12/15/2010EP2261657A2 Measurement of substances in liquids
12/15/2010EP2261656A1 Dry test instrument, method of measuring metal and method of producing dry test instrument
12/15/2010EP2261652A1 Stiffness detector, stiffness detection method, and paper sheet processor including stiffness detector
12/15/2010EP2261651A1 Methods for measuring physiological fluids
12/15/2010EP2261648A1 Electric analysis method
12/15/2010EP2261642A1 Gel particle measuring apparatus
12/15/2010EP2261639A1 Method and apparatus for measuring concentration of biological component
12/15/2010EP2261636A2 Cross-cut test device
12/15/2010EP2261597A1 Method and apparatus for detecting the three-dimensional structure of a log
12/15/2010EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261379A1 Method and system for detecting and/or quantifying bacteriophages, use of a microelectronic sensor device for detecting said bacteriophages and microelectronic sensor device for implementing said method
12/15/2010EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins
12/15/2010EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
12/15/2010EP2261370A1 Method for detecting abnormal spots of nucleic acid microarray
12/15/2010EP2261369A2 Gene expression profiling in biopsied tumor tissues
12/15/2010EP2261368A1 Gene expression profiling in biopsied tumor tissues
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions